👀Company Implants First PRIMA Chip in Stargardt Patient
A Step Closer to Restoring Vision for the Blind
TL;DR
Company implants its vision-restoring PRIMA chip into a patient with Stargardt disease, marking a significant step in treating currently incurable eye conditions. The chip, commercially available in Europe, offers hope for those with geographic atrophy.
Company has implanted its vision-restoring PRIMA chip into its first patient with Stargardt disease, an inherited eye condition that destroys central vision. This breakthrough is a game-changer for the 150,000 people worldwide affected by the disease. The PRIMA chip, about 2mm x 2mm, is placed in the back of the eye, working like artificial photoreceptors to restore vision. Patients wear camera-equipped glasses that transmit a view of the world to the chip. The first patient saw a letter in their first session and read a word in the second. The company plans to expand the field of view and develop a next-gen device for broader applications, including neurological conditions.
Key Points
Company's PRIMA chip is the first to be implanted in a Stargardt patient, offering hope to 150,000 affected worldwide.
The PRIMA chip, about 2mm x 2mm, is placed in the back of the eye, working like artificial photoreceptors.
Patients wear camera-equipped glasses that transmit a view of the world to the chip, restoring vision.
First patient saw a letter in their first session and read a word in the second, marking significant progress.
Company plans to expand the field of view and develop a next-gen device for broader applications, including neurological conditions.
Why It Matters
If you're a patient with Stargardt disease, the PRIMA chip offers hope for restoring central vision. The 2mm x 2mm implant, placed in the back of the eye, can help patients see again. However, the $0.20/GB-month premium for the glasses and chip setup means it's currently only viable for those with high read IOPS needs.
Comments
Be the first to comment
Enjoyed this article?
Get it daily. 7am. Free. Reads in 5 minutes.
Join 3,568 builders reading daily.